Success Metrics

Active Trials
2(40%)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Other(2)

Detailed Status

unknown2
Active, not recruiting1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 22 (40.0%)
N/A3 (60.0%)

Trials by Status

active_not_recruiting120%
recruiting120%
not_yet_recruiting120%
unknown240%

Recent Activity

2 active trials
Showing 5 of 5
not_yet_recruitingphase_2

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

NCT07698080
recruitingnot_applicable

Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

NCT06427642
active_not_recruitingnot_applicable

Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis

NCT05808010
unknownnot_applicable

Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis

NCT02721940
unknownphase_2

Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia

NCT01456819

Clinical Trials (5)

Showing 5 of 5 trials
NCT07698080Phase 2

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Not Yet Recruiting
NCT06427642Not Applicable

Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

Recruiting
NCT05808010Not Applicable

Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis

Active Not Recruiting
NCT02721940Not Applicable

Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis

Unknown
NCT01456819Phase 2

Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia

Unknown

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5